Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001088875-24-000081
Filing Date
2024-07-05
Accepted
2024-07-05 10:24:18
Documents
1

Document Format Files

Seq Description Document Type Size
1 alnylam28062024.txt SC 13G/A 9253
  Complete submission text file 0001088875-24-000081.txt   10950
Mailing Address CALTON SQUARE 1 GREENSIDE ROW EDINBURGH X0 EH13AN
Business Address CALTON SQUARE 1 GREENSIDE ROW EDINBURGH X0 EH13AN 00441312752000
BAILLIE GIFFORD & CO (Filed by) CIK: 0001088875 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0
Type: SC 13G/A

Mailing Address 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE MA 02142
Business Address 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Subject) CIK: 0001178670 (see all company filings)

EIN.: 770602661 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-79884 | Film No.: 241101862
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)